Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

GSK-3α/β monoclonal antibody (1H8)

ADI-KAM-ST002-D 50 µg 261.00 USD
ADI-KAM-ST002-F 200 µg 506.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: ALX-804-178

Product Details

Alternative Name:Glycogen synthase kinase-3α/β
Immunogen:Recombinant Xenopus GSK-3β.
UniProt ID:Q91757
Source:Purified from mouse ascites.
Species reactivity:Human, Mouse, Rat
Bovine, Dog, Hamster, Monkey, Porcine, Rabbit, Sheep
Applications:ICC, IHC, WB
Recommended Dilutions/Conditions:Western Blot (1:1,000, colorimetric)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
Application Notes:Detects bands of ~51 and ~47kDa by Western blot.
Purity Detail:Protein G affinity purified.
Formulation:Liquid. In PBS, pH 7.2, containing 50% glycerol and 0.09% sodium azide.
Shipping:Blue Ice
Long Term Storage:-20°C
Scientific Background:Glycogen Synthase Kinase 3β (GSK-3β) is a unique serine/threonine kinase that is inactivated by phosphorylation. In response to insulin binding, PKB/AKT phosphorylates GSK-3β on serine 9, which prevents GSK-3β from phosphorylating glycogen synthase. Unphosphorylated glycogen synthase is active and able to synthesize glycogen. GSK-3β is also unique in that it requires a substrate that has been phosphorylated by a distinct kinase before it can phosphorylate the substrate. This phosphate priming mechanism explains why phosphorylation of serine 9 inactivates GSK-3β. The phosphorylated serine binds to the GSK-3β priming phosphate position and prevents binding of alternative substrates. In addition to insulin signaling, GSK-3β participates in the Wnt signaling pathway, where it forms a complex with axin, beta-catenin and adenomatous polyposis coli (APC) protein. In the presence of Wnts, GSK-3β is unable to phosphorylate beta-catenin, which leads to stabilization of beta-catenin. The Wnt pathway inactivates GSK-3β via the proteins, Dishevelled and FRAT, which disrupt the interaction of GSK-3β with axin, beta-catenin, and APC. Clinically, there is considerable interest in GSK-3β inhibitors because they may mimic the effect of insulin or reduce the hyperphosphorylation of Tau that is observed in Alzheimer's Disease.
Regulatory Status:RUO - Research Use Only
GSK-3α/β monoclonal antibody (1H8) Western blot
Western blot analysis: Lane 1: MW marker, Lane 2: 20µg HeLa lysate (heat shocked), Lane 3: 20µg mouse brain lysate, Lane 4: 20µg rat brain lysate, Lane 5: 20µg RK-13 lysate.
Please mouse over
GSK-3α/β monoclonal antibody (1H8) Western blot

Product Literature References

Intracellular targets of paullones: identification following affinity purification on immobilized inhibitor: L. Meijer, et al. ; J. Biol. Chem. 277, 25493 (2002), Application(s): WB using porcine & rat samples, Abstract;

Related Products

Goat anti-mouse IgG, polyclonal antibody (AP conjugate) 

ELISA, WB | Print as PDF
ADI-SAB-101-J 1 ml 175.00 USD
Do you need bulk/larger quantities?

HeLa (heat shocked) , (cell lysate) 

Human, WB | Print as PDF
ADI-LYC-HL101-F 200 µg 141.00 USD
Do you need bulk/larger quantities?

Brain (rat), (tissue extract) 

Rat brain extract, WB | Print as PDF
ADI-LYT-RB100-F 200 µg 225.00 USD
Do you need bulk/larger quantities?

Related Literature

Integrated solutions for screening Wnt regulators
Integrated solutions for screening Wnt regulators
Download as PDF

Stem Cells
Stem Cells
Download as PDF

Download as PDF

All new literature pieces